Because NVP-BEZ235 equally inhibits the mutant and wild-type forms of PIK3CA, we hypothesized that NVP-BEZ235 would have significant efficacy in human wild-type PIK3CA CRC [32]. This evidence concerns the gene PIK3CA and colorectal carcinoma.